DANVERS, Mass.--(BUSINESS WIRE)--BioChemics announced today that the United States Patent and Trademark Office issued U.S. Patent No. 8,343,486 entitled “Methods and Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation” to BioChemics, Inc., a biotechnology company located in Danvers, MA. The patent, which was filed and prosecuted by Sunstein Kann Murphy and Timbers LLP, issued on January 1, 2013 and will expire February 26, 2031.
